Suven Pharmaceuticals
December 26, 2022
Private Equity major, Advent has confirmed that it has entered into a definitive agreement to acquire a controlling stake in Suven Pharmaceuticals (SP). Advent is acquiring 50.1% from the promoters ... Read more
Do you have something important to share about the Company?
Subscribe
Login
0 Comments
Inline Feedbacks
View all comments